| Hoo lordy, this is just plain desperate: As part of the health care cost-control plan, Sen. President Murray has proposed to eliminate pharma companies' bribes gifties to doctors. And now WAAAAATCH OUT! Glaxo's gonna pull up stakes and ship right out! It's so obvious: Our health care waste-spending is someone else's revenue stream. But make no mistake -- this jacked-up threat is a sign of Glaxo's weakness. The threat is such that it exposes how little a case Glaxo has on the merits. Just a straight-up power play, but it's just got to be a bluff. Glaxo's got all of 115 jobs here; we've got a huge pot-sweetener on the way in the biotech bill (as Glaxo's CEO even acknowledges), and we've got the inherent brainpower advantages that we've always had. Life sciences are cookin' in MA -- who doesn't want some of that action? Furthermore, their complaints about what the bill does and doesn't do are straight-up FUD -- in other words, horsehockey. Docs can still talk to reps. Docs can still even work for pharma co's. They just can't take those nifty gifties. Clear as day. The response by Patrick and DiMasi's spokespeople has been very very weak tea indeed: A spokeswoman for DiMasi said the speaker opposes “criminalization” of gift giving, though wouldn’t comment further. A spokesman for Patrick said Murray’s bill contains “really good ideas” but the governor is still reviewing the gift-ban provision. Lame. Not exactly Profiles in Courage time -- particularly surprising from DiMasi, seeing as he's the man most responsible for Chapter 58, which law's very existence is threatened by rising health care costs.
If you want to contain costs, you gotta piss some people off. Massachusetts' immense strengths in the biotech mean a hell of a lot more than banning their right to (legally) bribe docs. Call the bluff, everyone. (There are a lot more to come.) |